Education
About Us
Working with TipRanks
Follow Us
Matthew L. Kaplan Insider Profile
4 Followers
Matthew L. Kaplan, Director at Nuvectis Pharma, holds 124.76K shares in Nuvectis Pharma (Ticker: NVCT). Most recently, Matthew L. Kaplan Bought 11,000 shares of Nuvectis Pharma on Nov 06, 2025 for an estimated value of $64.24K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+3.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew L. Kaplan's holdings
Insider Roles
Director
Roles that Matthew L. Kaplan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew L. Kaplan
Matthew L. Kaplan's Trading History
List of latest transactions for each holding click on a transaction to see Matthew L. Kaplan's performance on stock
You May Also Like
Matthew L. Kaplan insider profile FAQ
What is the percentage of profitable transactions made by Matthew L. Kaplan?
The percentage of profitable transactions made by Matthew L. Kaplan is 50%.
What is the average return per transaction made by Matthew L. Kaplan?
The average return per transaction made by Matthew L. Kaplan is 3.60%.
What stocks does Matthew L. Kaplan hold?
Matthew L. Kaplan holds: NVCT stocks.
What was Matthew L. Kaplan’s latest transaction?
Matthew L. Kaplan latest transaction was an Informative Buy of $64.24K.
What was Matthew L. Kaplan's most profitable transaction?
Matthew L. Kaplan’s most profitable transaction was an Informative Buy of NVCT stock on November 6, 2025. The return on the trade was 18.30%.
What is Matthew L. Kaplan's role in Nuvectis Pharma?
Matthew L. Kaplan's role in Nuvectis Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.